PPA
STRO icon

Parametric Portfolio Associates’s Sutro Biopharma STRO Stock Holding History

Parametric Portfolio Associates’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$94K Sell
1,146
-1,175
-51% -$112K ﹤0.01% 3573
2021
Q4 		$345K Buy
2,321
+1,239
+115% +$222K ﹤0.01% 3229
2021
Q3 		$204K Sell
1,082
-141
-12% -$26.8K ﹤0.01% 3435
2021
Q2 		$227K Sell
1,223
-411
-25% -$80.4K ﹤0.01% 3361
2021
Q1 		$372K Buy
+1,634
New +$388K ﹤0.01% 3627

Other funds holding STRO

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Parametric Portfolio Associates's STRO Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Sutro Biopharma (STRO) stake by 51% in Q1 2022, selling an estimated $112K and leaving 1,146 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

Parametric Portfolio Associates first reported a position in STRO in Q1 2021 and has held it in 5 quarters since. The position peaked at $372K in Q1 2021. 115 funds tracked by Wall St. Rank hold STRO as of Q1 2022.

  • Parametric Portfolio Associates held 1,146 shares of Sutro Biopharma worth $94K as of Q1 2022.
  • Parametric Portfolio Associates sold 1,175 Sutro Biopharma shares in Q1 2022, an estimated $112K.
  • Sutro Biopharma made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3573 holding.
  • Parametric Portfolio Associates first reported a position in Sutro Biopharma in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Sutro Biopharma position peaked at $372K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.